243 related articles for article (PubMed ID: 31995002)
1. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
3. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
Hahm ER; Lee J; Huang Y; Singh SV
Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
5. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.
Choudhary MI; Hussain S; Yousuf S; Dar A; Mudassar ; Atta-ur-Rahman
Phytochemistry; 2010 Dec; 71(17-18):2205-9. PubMed ID: 21044792
[TBL] [Abstract][Full Text] [Related]
6. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
7. Interaction Studies of Withania Somnifera's Key Metabolite Withaferin A with Different Receptors Assoociated with Cardiovascular Disease.
Ravindran R; Sharma N; Roy S; Thakur AR; Ganesh S; Kumar S; Devi J; Rajkumar J
Curr Comput Aided Drug Des; 2015; 11(3):212-21. PubMed ID: 26548552
[TBL] [Abstract][Full Text] [Related]
8. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
[TBL] [Abstract][Full Text] [Related]
9. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
Vadloori B; Sharath AK; Prabhu NP; Maurya R
BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
[TBL] [Abstract][Full Text] [Related]
10. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study.
Cai Z; Zhang G; Tang B; Liu Y; Fu X; Zhang X
Cell Biochem Biophys; 2015 Jul; 72(3):727-39. PubMed ID: 25627548
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
[No Abstract] [Full Text] [Related]
13. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
[TBL] [Abstract][Full Text] [Related]
14.
Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog inhibitors from Withania somnifera.
Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the inhibitory potential of Withania somnifera on platelet aggregation and inflammation enzymes: An in vitro and in silico study.
M M; Zameer F; Naidu A; M N NP; Dhananjaya BL; Hegdekatte R
Pharm Biol; 2016 Sep; 54(9):1936-41. PubMed ID: 26704448
[TBL] [Abstract][Full Text] [Related]
17. In Silico Study on the Interactions, Molecular Docking, Dynamics and Simulation of Potential Compounds from
Deshpande SH; Muhsinah AB; Bagewadi ZK; Ankad GM; Mahnashi MH; Yaraguppi DA; Shaikh IA; Khan AA; Hegde HV; Roy S
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770785
[TBL] [Abstract][Full Text] [Related]
18. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
19. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
[TBL] [Abstract][Full Text] [Related]
20. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
